...
首页> 外文期刊>British Journal of Cancer >Peroxisome proliferator-activated receptor |[gamma]| ligand-induced growth inhibition of human hepatocellularcarcinoma
【24h】

Peroxisome proliferator-activated receptor |[gamma]| ligand-induced growth inhibition of human hepatocellularcarcinoma

机译:过氧化物酶体增殖物激活受体|γ|配体诱导的人肝癌细胞生长抑制

获取原文

摘要

Peroxisome proliferator-activated receptor γ (PPARγ) ligands have been implicated in the growth inhibition and differentiation of certain human cancers with diverse tissue origin. In this study, expression of PPARγ in human hepatocellular carcinoma (HCC) and the effect of PPARγ ligands on HCC cells were investigated in vitro using Hep G2, HuH-7, KYN-1 and KYN-2 cell lines. All cell lines were found to express functionally active PPARγ and a marked growth inhibition was induced by thiazolidinedione ligands troglitazone, and pioglitazone as well as with its natural ligand 15-deoxy-Δ12,14-prostaglandin J2. The growth inhibitory effect was associated with a dose-dependent inhibition of DNA synthesis, cell cycle progression and α fetoprotein expression. ? 2001 Cancer Research Campaign http://www.bjcancer.com
机译:过氧化物酶体增殖物激活的受体γ(PPARγ)配体已与某些具有不同组织起源的人类癌症的生长抑制和分化有关。在这项研究中,使用Hep G2,HuH-7,KYN-1和KYN-2细胞系研究了PPARγ在人肝细胞癌(HCC)中的表达以及PPARγ配体对HCC细胞的影响。发现所有细胞系均表达功能活性的PPARγ,噻唑烷二酮配体曲格列酮,吡格列酮及其天然配体15-脱氧-Δ12,14-前列腺素J2诱导了明显的生长抑制。该生长抑制作用与DNA合成,细胞周期进程和甲胎蛋白表达的剂量依赖性抑制有关。 ? 2001年癌症研究运动http://www.bjcancer.com

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号